Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer.

Yo Han Park, Jae Im Lee, Jong Kyung Park, Hang Ju Jo, Won Kyung Kang, Chang Hyeok An
{"title":"Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer.","authors":"Yo Han Park,&nbsp;Jae Im Lee,&nbsp;Jong Kyung Park,&nbsp;Hang Ju Jo,&nbsp;Won Kyung Kang,&nbsp;Chang Hyeok An","doi":"10.3393/jksc.2011.27.5.260","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Recent literature has shown that lymph node ratio is superior to the absolute number of metastatic lymph nodes in predicting the prognosis in several malignances other than colorectal cancer. The aim of this study was to evaluate the prognostic significance of the lymph node ratio (LNR) in patients with stage III colorectal cancer.</p><p><strong>Methods: </strong>We included 186 stage III colorectal cancer patients who underwent a curative resection over a 10-year period in one hospital. The cutoff point of LNR was chosen as 0.07 because there was significant survival difference at that LNR. The Kaplan-Meier and the Cox proportional hazard models were used to evaluate the prognostic effect according to LNR.</p><p><strong>Results: </strong>There was statistically significant longer overall survival in the group of LNR > 0.07 than in the group of LNR ≤ 7 (P = 0.008). Especially, there was a survival difference for the N1 patients group (LN < 4) according to LNR (5-year survival of N1 patients was lower in the group of LNR > 0.07, P = 0.025), but there was no survival difference for the N2 group (4 ≥ LN) according to LNR. The multivariate analysis showed that the LNR is an independent prognostic factor.</p><p><strong>Conclusions: </strong>LNR can be considered as a more accurate and potent modality for prognostic stratifications in patients with stage III colorectal cancer.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/1f/jksc-27-260.PMC3218131.pdf","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Korean Society of Coloproctology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3393/jksc.2011.27.5.260","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/10/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Purpose: Recent literature has shown that lymph node ratio is superior to the absolute number of metastatic lymph nodes in predicting the prognosis in several malignances other than colorectal cancer. The aim of this study was to evaluate the prognostic significance of the lymph node ratio (LNR) in patients with stage III colorectal cancer.

Methods: We included 186 stage III colorectal cancer patients who underwent a curative resection over a 10-year period in one hospital. The cutoff point of LNR was chosen as 0.07 because there was significant survival difference at that LNR. The Kaplan-Meier and the Cox proportional hazard models were used to evaluate the prognostic effect according to LNR.

Results: There was statistically significant longer overall survival in the group of LNR > 0.07 than in the group of LNR ≤ 7 (P = 0.008). Especially, there was a survival difference for the N1 patients group (LN < 4) according to LNR (5-year survival of N1 patients was lower in the group of LNR > 0.07, P = 0.025), but there was no survival difference for the N2 group (4 ≥ LN) according to LNR. The multivariate analysis showed that the LNR is an independent prognostic factor.

Conclusions: LNR can be considered as a more accurate and potent modality for prognostic stratifications in patients with stage III colorectal cancer.

Abstract Image

Abstract Image

Abstract Image

结直肠癌III期淋巴结比例的临床意义。
目的:近期文献显示,在预测除结直肠癌以外的几种恶性肿瘤的预后时,淋巴结比例优于转移淋巴结的绝对数量。本研究的目的是评估淋巴结比例(LNR)在III期结直肠癌患者中的预后意义。方法:我们纳入186例在一家医院接受10年治愈性切除的III期结直肠癌患者。LNR的临界值为0.07,因为在该LNR处存在显著的生存差异。根据LNR采用Kaplan-Meier和Cox比例风险模型评价预后效果。结果:LNR > 0.07组总生存期长于LNR≤7组,差异有统计学意义(P = 0.008)。其中N1组(LN < 4)按LNR有生存差异(LNR > 0.07组N1患者5年生存率较低,P = 0.025), N2组(4≥LN)按LNR无生存差异。多因素分析显示LNR是一个独立的预后因素。结论:LNR可被认为是III期结直肠癌患者预后分层的更准确和有效的方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信